Drawing for AMRYT

USPTO serial 79201890

AMRYT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SEVERSON, KAREN
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AMRYT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of epidermolysis bullosa, dermatological diseases and disorders, acromegaly, endocrine disorders, neuroendocrine disorders, Cushing's Disease, tumors, homozygous familial hypercholesterolemia, high blood cholesterol, metabolic diseases and disorders, infectious diseases, immune system diseases and disorders, blood diseases and disorders, oncological diseases and disorders, genitourinary diseases and disorders, pain, inflammatory and autoimmune diseases and disorders, gastrointestinal diseases and disorders, neurological diseases and disorders, respiratory diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders and pharmaceutical preparations for destroying parasitesACTIVE—
010Medical devices, namely, medical syringes, inhalers for medical use, drug delivery patches sold without medication, infusion and injection devices for administering drugsACTIVE—
042Medical and pharmaceutical research; scientific services in the medical and pharmaceutical field, namely, pharmaceutical drug development services; pharmaceutical research, namely, conducting clinical trials for others in the field of pharmaceuticalACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2023LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jul 30, 2023RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Jul 19, 2022LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jun 11, 2022RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
May 17, 2022LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 8, 2022RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Jan 7, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 8, 2021CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Sep 19, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 24, 2020LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Sep 11, 2020RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Jul 9, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 31, 2019FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
May 10, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 10, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 10, 2018OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 25, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 25, 2018OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 10, 2018MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 10, 2018ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 12, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 12, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 12, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 15, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 13, 2017ALIEASSIGNED TO LIE—
Sep 8, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 7, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 7, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 7, 2017RFRRREFUSAL PROCESSED BY MPU—
Mar 4, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 3, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 27, 2017DOCKASSIGNED TO EXAMINER—
Feb 24, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance